When did Immunome report Q4 2024 earnings?

Immunome (IMNM) reported Q4 2024 earnings on March 19, 2025 before market open.

What were Immunome's Q4 2024 revenue and EPS?

Immunome reported revenue of $2.7M and diluted EPS of $-0.84 for Q4 2024.

Did Immunome beat estimates in Q4 2024?

Revenue missed the consensus estimate of $3.1M by $408.9K. EPS missed the consensus estimate of $-0.68 by $0.16.

Where can I find Immunome's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001558370-25-003302) directly on SEC EDGAR. The filing index links above go to sec.gov.

Immunome IMNM Q4 2024 Annual earnings

Reported March 19, 2025 · Before market open

Revenue$2.7MMiss by $408.9K Diluted EPS-$0.84Miss by $0.16

Revenue estimate$3.1M

EPS estimate-$0.68

Next report

Aug 5, 2026 (In 3 weeks)

Revenue estimate$166.7K

EPS estimate-$0.51

Financials

Q4 2024

Income statement

See full

Revenue$2.7M-28.4%

Operating income-$83.0M+12.3%

Net income-$80.2M+13.4%

EPS (diluted)-$1.28+69.7%

Balance sheet

See full

Cash & equivalents$143.4M+45.3%

Total debt$4.8M+193%

Total equity$181.2M+51.1%

Total assets$240.2M+61.7%

Cash flow

See full

Operating cash flow-$42.1M-141%

CapEx$1.1M+223%

Free cash flow-$43.2M-143%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$662.87M+45.0%

Enterprise value$524.35M+45.6%

P/S73.3×+40.7×

Profitability

See full

Operating margin-3,382.4%-4,835pp

Net margin-3,240.4%-4,679pp

FCF margin-1,304.8%—

Returns & leverage

See full

Return on equity-194.6%+62.8pp

Debt / equity0×0.0×

Current ratio4.1×-2.6×

Versus estimates

Revenue

Q2 2025$4.0MBeat by $3.2M Q1 2025$2.9MBeat by $2.5M

Q4 2024$2.7MMiss by $408.9K

Diluted EPS

Q1 2026-$0.48Beat by $0.12 Q4 2025-$0.75Miss by $0.16 Q3 2025-$0.65Miss by $0.08 Q2 2025-$0.50Beat by $0.02 Q1 2025-$0.52Beat by $0.14

Q4 2024-$0.84Miss by $0.16

Ask the moment Immunome reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Immunome report Q4 2024 earnings?: Immunome (IMNM) reported Q4 2024 earnings on March 19, 2025 before market open.
What were Immunome's Q4 2024 revenue and EPS?: Immunome reported revenue of $2.7M and diluted EPS of $-0.84 for Q4 2024.
Did Immunome beat estimates in Q4 2024?: Revenue missed the consensus estimate of $3.1M by $408.9K. EPS missed the consensus estimate of $-0.68 by $0.16.
Where can I find Immunome's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001558370-25-003302) directly on SEC EDGAR. The filing index links above go to sec.gov.